How generic cyclosporine might affect optometryI foresee every dry eye script I write to be “changed” to generic cyclosporine. This means optometrists will be straddled with more burdensome prior authorizations and delays for the patients.
In this issue
Know the benefits of adopting neuroimagingNeuroimaging can help ODs better treat patients with possible tumor, vascular disorder, or demyelinating disease. CT scans are used for bone fractures and vascular disorders as well as orbital and pituitary tumors. MRIs are best gliomas and menigiomas and screening for vascular disorders. Communicate to radiology patient history and what you are trying to rule out when ordering tests. Clinical findings supported by new OCTA technology November 14, 2017By Leo Semes OD FAAOSince its FDA clearance, the significant potential of OCTA has been emphasized. 6 tips to address, survive one-star online reviews November 15, 2017By Diana Canto-Sims ODIf you have not yet received a bad review, it is coming. It is only a matter of time. Have you Googled your practice recently? Anyone with a smartphone, social media account, or an email account can go online and rant about anything—including your practice. ODs’ role promising in detecting Alzheimer’s disease November 15, 2017By Stuart Richer OD PhDScience is evolving, and practices will soon find themselves in a moral quagmire. Detection and clinical staging of AD using vision and ophthalmic imaging are close at hand. How OCT can help a smaller practice November 16, 2017By Christina Petrou ODSpectral domain optical coherence tomography (SD-OCT) has grown in importance to optometric patient care. One OD shares her experience of moving from quarterly use of a rented device to purchasing an OCT for her small private practice and how it has improved clinical care and patient education. Q&A: Michele Andrews, OD—Senior director, North America, Professional and Academic Affairs, Cooper Vision November 17, 2017By Vernon TrollingerIf optometry could adapt a bit more readily and not be so fearful of change, we could continue to be an amazing profession, evolve with customer demand, and serve our customers in the way they want. Following Occam’s razor in optometryI believe that the future of optometry, with all its hitches, challenges, and opportunities, is best met head-on if we all communicate effectively with one another. How tear osmolarity affects lens wearConsidering that many CL patients are desensitized, it is critical we not only monitor their tear film and ocular surface for change, but we demonstrate stability or instability through measurable means. This creates trust, validates our recommendations, induces compliance, and generates positive outcomes.